Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

C16:1OH 3-hydroxyhexadecenoylcarnitine

Immunology & Autoimmune

3-hydroxyhexadecenoylcarnitineC16:1-OH

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the level of C16:1OH, also called 3-hydroxyhexadecenoylcarnitine, in your blood. C16:1OH is one of the long-chain acylcarnitines formed when the body breaks down fats for energy. Laboratories detect it using tandem mass spectrometry as part of an acylcarnitine profile.

C16:1OH is especially useful in evaluating how your cells handle long-chain fatty acids. It is commonly included in newborn screening and in follow-up testing when a fatty acid oxidation condition is suspected.

Why it matters

Abnormal levels of C16:1OH can point to problems using long-chain fats for energy, such as long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency or mitochondrial trifunctional protein deficiency. These conditions can lead to low blood sugar, muscle symptoms, heart involvement, or liver stress, especially during fasting or illness.

Clinicians use this result together with other acylcarnitines, clinical history, and additional laboratory tests to decide on next steps. Finding a pattern that suggests a fatty acid oxidation disorder can guide urgent dietary changes and confirmatory testing, which may reduce the risk of metabolic crises.

Understanding your results

Your result is interpreted using age-appropriate reference intervals and by looking at patterns across related acylcarnitines. A single out-of-range result does not confirm a diagnosis. If your level is higher than expected, your clinician may order a repeat sample, a full acylcarnitine profile, organic acids, urine acylglycines, and genetic testing to clarify the cause.

If you or your child has symptoms such as poor feeding, lethargy, vomiting, muscle pain, dark urine, or episodes during illness, share this information with your care team, since it helps interpret the result. Even if the value is within the expected range, your clinician may continue evaluation if there is strong clinical concern, because some conditions show changes only during stress or fasting.

Reference ranges

00.04 umol/L
All sexes
0 days – 7 days
00.03 umol/L
All sexes
7 days – 1 month
00.02 umol/L
All sexes
1 month – 12 months
00.03 umol/L
All sexes
12 months – 13 years
00.03 umol/L
All sexes
13 years – 19 years
00.03 umol/L
All sexes
19 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact C16:1OH 3-hydroxyhexadecenoylcarnitine

  • Fasting and illness

    Fasting, fever, or viral illness can shift the body to fat use, which may raise long-chain acylcarnitines, including C16:1OH. Tell your care team about recent illness, reduced intake, or strenuous exercise.

  • Age and timing of sample

    Newborn and early infant values differ from those in older children and adults. Early postnatal adaptation, prematurity, and timing from birth can influence acylcarnitine patterns.

  • Nutritional supplements and TPN

    Carnitine supplements, specialized formulas, or total parenteral nutrition can alter acylcarnitine profiles. Share details of any supplements, formulas, or lipid emulsions used.

  • Sample type and handling

    Results can vary between dried blood spots and plasma, and with delayed transport or improper storage. Proper collection and prompt processing help ensure reliable values.

  • Medications and fuels

    Some medicines and energy drinks change fat metabolism or carnitine availability, which can affect acylcarnitines. Provide a complete list of medications and over-the-counter products.

  • Maternal and newborn factors

    For newborns, maternal metabolic status, intrapartum stress, and feeding patterns can influence early results. Follow-up testing often confirms whether an initial finding persists.

2026

References

  1. McGill University Health Centre. (2019, June 07). C16:1OH 3OHhexadecenoyl (Task CD 22021163). Laboratory reference ranges.
  2. American College of Medical Genetics and Genomics. (2020). ACT Sheet: Elevated C16OH and/or C18:1OH acylcarnitines suggesting long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency.
  3. Vockley, J., Burton, B. K., et al. (2019). Diagnosis and management of long-chain fatty acid oxidation disorders: A clinical practice resource. Genetics in Medicine, 21(3), 486-494.